{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:38:00Z","timestamp":1791081480826,"version":"4.1.0"},"reference-count":54,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,7,14]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>IL-21 is a proinflammatory cytokine produced by Th17 cells. Abrogation of IL-21 signaling has recently been shown to reduce GVHD while retaining graft-versus-leukemia\/lymphoma (GVL) responses. However, the mechanisms by which IL-21 may lead to a separation of GVHD and GVL remain incompletely understood. In a murine MHC-mismatched BM transplantation model, we observed that IL-21 receptor knockout (IL-21R KO) donor T cells mediate decreased systemic and gastrointestinal GVHD in recipients of a transplant. This reduction in GVHD was associated with expansion of transplanted donor regulatory T cells and with tissue-specific modulation of Th-cell function. IL-21R KO and wild-type donor T cells showed equivalent alloactivation, but IL-21R KO T cells showed decreased infiltration and inflammatory cytokine production within the mesenteric lymph nodes. However, Th-cell cytokine production was maintained peripherally, and IL-21R KO T cells mediated equivalent immunity against A20 and P815 hematopoietic tumors. In summary, abrogation of IL-21 signaling in donor T cells leads to tissue-specific modulation of immunity, such that gastrointestinal GVHD is reduced, but peripheral T-cell function and GVL capacity are retained. IL-21 is thus an exciting target for therapeutic intervention and improvement of clinical transplantation outcomes.<\/jats:p>","DOI":"10.1182\/blood-2010-07-294785","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T05:19:37Z","timestamp":1305868777000},"page":"446-455","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":62,"title":["Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL"],"prefix":"10.1182","volume":"118","author":[{"given":"Alan M.","family":"Hanash","sequence":"first","affiliation":[{"name":"Departments of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy W.","family":"Kappel","sequence":"additional","affiliation":[{"name":"Immunology, Memorial Sloan-Kettering Cancer Center, New York, NY;"},{"name":"Department of Immunology and Microbial Pathogenesis, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nury L.","family":"Yim","sequence":"additional","affiliation":[{"name":"Immunology, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Nejat","sequence":"additional","affiliation":[{"name":"Immunology, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle L.","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Immunology, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odette M.","family":"Smith","sequence":"additional","affiliation":[{"name":"Immunology, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttam K.","family":"Rao","sequence":"additional","affiliation":[{"name":"Immunology, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Dykstra","sequence":"additional","affiliation":[{"name":"Immunology, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Kang","family":"Na","sequence":"additional","affiliation":[{"name":"Immunology, Memorial Sloan-Kettering Cancer Center, New York, NY;"},{"name":"Department of Hematology and Oncology, Charit\u00e9 CBF-Universit\u00e4tsmedizin Berlin, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Holland","sequence":"additional","affiliation":[{"name":"Immunology, Memorial Sloan-Kettering Cancer Center, New York, NY;"},{"name":"Department of Immunology and Microbial Pathogenesis, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarrod A.","family":"Dudakov","sequence":"additional","affiliation":[{"name":"Immunology, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George F.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Program in Dermatopathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren J.","family":"Leonard","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Heller","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel R. M.","family":"van den Brink","sequence":"additional","affiliation":[{"name":"Departments of Medicine and"},{"name":"Immunology, Memorial Sloan-Kettering Cancer Center, New York, NY;"},{"name":"Department of Immunology and Microbial Pathogenesis, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5","key":"2019111806525622700_B1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri2000","article-title":"Graft-versus-host disease.","volume":"7","author":"Shlomchik","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2019111806525622700_B2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nri775","article-title":"Cytolytic pathways in haematopoietic stem-cell transplantation.","volume":"2","author":"van den Brink","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"2019111806525622700_B3","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood.V95.9.2754.009k25_2754_2759","article-title":"The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation.","volume":"95","author":"Hill","year":"2000","journal-title":"Blood"},{"issue":"4","key":"2019111806525622700_B4","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1182\/blood-2003-03-0957","article-title":"LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease.","volume":"103","author":"Petrovic","year":"2004","journal-title":"Blood"},{"issue":"4","key":"2019111806525622700_B5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hon.716","article-title":"Pathophysiology of acute graft-versus-host disease.","volume":"21","author":"Reddy","year":"2003","journal-title":"Hematol Oncol"},{"issue":"1","key":"2019111806525622700_B6","first-page":"7","article-title":"Current use and outcome of hematopoietic stem cell transplantation, Part I: CIBMTR Summary Slides, 2009.","volume":"15","author":"Pasquini","year":"2009","journal-title":"CIBMTR Newslett"},{"issue":"3\u20134","key":"2019111806525622700_B7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cytogfr.2007.04.003","article-title":"Interleukin-21: a new modulator of immunity, infection, and cancer.","volume":"18","author":"Brandt","year":"2007","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"2019111806525622700_B8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.coi.2008.02.004","article-title":"The Yin and yang of interleukin-21 in allergy, autoimmunity and cancer.","volume":"20","author":"Spolski","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"2019111806525622700_B9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.immunol.26.021607.090316","article-title":"Interleukin-21: basic biology and implications for cancer and autoimmunity.","volume":"26","author":"Spolski","year":"2008","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"2019111806525622700_B10","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.4049\/jimmunol.176.7.4163","article-title":"Expression of the adaptor protein hematopoietic Src homology 2 is up-regulated in response to stimuli that promote survival and differentiation of B cells.","volume":"176","author":"Herrin","year":"2006","journal-title":"J Immunol"},{"issue":"9","key":"2019111806525622700_B11","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.4049\/jimmunol.173.9.5361","article-title":"Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6.","volume":"173","author":"Ozaki","year":"2004","journal-title":"J Immunol"},{"issue":"9","key":"2019111806525622700_B12","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","article-title":"IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways.","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat Immunol"},{"issue":"11","key":"2019111806525622700_B13","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1002\/eji.200737766","article-title":"IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells.","volume":"37","author":"Fantini","year":"2007","journal-title":"Eur J Immunol"},{"issue":"7152","key":"2019111806525622700_B14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature05970","article-title":"IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells.","volume":"448","author":"Korn","year":"2007","journal-title":"Nature"},{"issue":"1","key":"2019111806525622700_B15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20041057","article-title":"Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function.","volume":"201","author":"Zeng","year":"2005","journal-title":"J Exp Med"},{"issue":"3","key":"2019111806525622700_B16","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/art.20883","article-title":"Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.","volume":"52","author":"Distler","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2019111806525622700_B17","doi-asserted-by":"crossref","first-page":"e3118","DOI":"10.1371\/journal.pone.0003118","article-title":"IL-21 limits peripheral lymphocyte numbers through T cell homeostatic mechanisms.","volume":"3","author":"Datta","year":"2008","journal-title":"PLoS ONE"},{"issue":"3","key":"2019111806525622700_B18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1053\/j.gastro.2004.12.042","article-title":"Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease.","volume":"128","author":"Monteleone","year":"2005","journal-title":"Gastroenterology"},{"issue":"6","key":"2019111806525622700_B19","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1182\/blood-2002-07-2109","article-title":"Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation.","volume":"101","author":"Schmaltz","year":"2003","journal-title":"Blood"},{"issue":"2","key":"2019111806525622700_B20","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4049\/jimmunol.157.2.689","article-title":"IL-12 is a central mediator of acute graft-versus-host disease in mice.","volume":"157","author":"Williamson","year":"1996","journal-title":"J Immunol"},{"issue":"6","key":"2019111806525622700_B21","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1097\/00007890-199312000-00045","article-title":"Interleukin-1 is a critical effector molecule during cytokine dysregulation in graft versus host disease to minor histocompatibility antigens.","volume":"56","author":"Abhyankar","year":"1993","journal-title":"Transplantation"},{"issue":"4","key":"2019111806525622700_B22","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood-2008-08-172155","article-title":"IL-17 contributes to CD4-mediated graft-versus-host disease.","volume":"113","author":"Kappel","year":"2009","journal-title":"Blood"},{"issue":"10","key":"2019111806525622700_B23","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1182\/blood-2008-08-175448","article-title":"Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease.","volume":"113","author":"Das","year":"2009","journal-title":"Blood"},{"issue":"26","key":"2019111806525622700_B24","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1182\/blood-2009-05-221135","article-title":"IL-21 blockade reduces graft-versus-host-disease mortality by supporting inducible T regulatory cell generation.","volume":"114","author":"Bucher","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2019111806525622700_B25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/bmt.2009.223","article-title":"IL-21 is critical for GVHD in a mouse model.","volume":"45","author":"Meguro","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2019111806525622700_B26","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.4049\/jimmunol.0902217","article-title":"Altered effector CD4+ T cell function in IL-21R-\/- CD4+ T cell-mediated graft-versus-host disease.","volume":"185","author":"Oh","year":"2010","journal-title":"J Immunol"},{"issue":"5","key":"2019111806525622700_B27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1182\/blood-2009-11-256495","article-title":"Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma.","volume":"116","author":"Hill","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2019111806525622700_B28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2482","article-title":"Interleukin 21: combination strategies for cancer therapy.","volume":"7","author":"Skak","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2019111806525622700_B29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4049\/jimmunol.173.1.657","article-title":"Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis.","volume":"173","author":"Jin","year":"2004","journal-title":"J Immunol"},{"key":"2019111806525622700_B30","article-title":"Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cells [published online ahead of print January 24, 2011].","author":"Meguro","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2019111806525622700_B31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/blood-2009-12-257253","article-title":"In vivo administration of hypomethylating agents mitigate graft-versus-host disease (GvHD) without sacrificing graft-versus-leukemia (GvL).","volume":"116","author":"Choi","year":"2010","journal-title":"Blood"},{"issue":"9","key":"2019111806525622700_B32","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm915","article-title":"CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.","volume":"9","author":"Edinger","year":"2003","journal-title":"Nat Med"},{"issue":"4","key":"2019111806525622700_B33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/bbmt.2003.50027","article-title":"Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.","volume":"9","author":"Jones","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2019111806525622700_B34","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI17702","article-title":"Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia.","volume":"112","author":"Trenado","year":"2003","journal-title":"J Clin Invest"},{"issue":"3","key":"2019111806525622700_B35","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/sj.leu.2404522","article-title":"Increased frequencies of CD4+CD25high Tregs correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia.","volume":"21","author":"Nadal","year":"2007","journal-title":"Leukemia"},{"issue":"2","key":"2019111806525622700_B36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.coi.2007.02.004","article-title":"Regulatory T cells and cancer.","volume":"19","author":"Wang","year":"2007","journal-title":"Current Opinion in Immunology"},{"issue":"2","key":"2019111806525622700_B37","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s10875-010-9368-7","article-title":"Th17 cytokines and the gut mucosal barrier.","volume":"30","author":"Blaschitz","year":"2010","journal-title":"J Clin Immunol"},{"key":"2019111806525622700_B38","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.0105-2896.2005.00285.x","article-title":"Lymphocyte homing to the gut: attraction, adhesion, and commitment.","volume":"206","author":"Salmi","year":"2005","journal-title":"Immunol Rev"},{"issue":"3","key":"2019111806525622700_B39","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood-2005-02-0509","article-title":"In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets.","volume":"106","author":"Beilhack","year":"2005","journal-title":"Blood"},{"issue":"9","key":"2019111806525622700_B40","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1182\/blood-2003-08-2827","article-title":"In vivo imaging of graft-versus-host-disease in mice.","volume":"103","author":"Panoskaltsis-Mortari","year":"2004","journal-title":"Blood"},{"issue":"8","key":"2019111806525622700_B41","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/intimm\/7.8.1183","article-title":"Involvement of alpha 1 and alpha 4 integrins in gut mucosal injury of graft-versus-host disease.","volume":"7","author":"Tanaka","year":"1995","journal-title":"Int Immunol"},{"issue":"5","key":"2019111806525622700_B42","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1182\/blood-2007-06-096602","article-title":"Organ-derived dendritic cells have differential effects on alloreactive T cells.","volume":"111","author":"Kim","year":"2008","journal-title":"Blood"},{"issue":"4","key":"2019111806525622700_B43","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2005-08-3445","article-title":"Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine.","volume":"107","author":"Waldman","year":"2006","journal-title":"Blood"},{"issue":"1","key":"2019111806525622700_B44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0092-8674(00)80059-8","article-title":"CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs.","volume":"99","author":"Forster","year":"1999","journal-title":"Cell"},{"issue":"23","key":"2019111806525622700_B45","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1182\/blood-2009-08-239848","article-title":"Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells.","volume":"115","author":"Coghill","year":"2010","journal-title":"Blood"},{"issue":"8","key":"2019111806525622700_B46","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/intimm\/dxn059","article-title":"IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytes.","volume":"20","author":"Ferrari-Lacraz","year":"2008","journal-title":"Int Immunol"},{"issue":"3","key":"2019111806525622700_B47","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1034\/j.1399-0012.2001.150301.x","article-title":"Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin.","volume":"15","author":"Remberger","year":"2001","journal-title":"Clin Transplant"},{"issue":"5","key":"2019111806525622700_B48","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.4049\/jimmunol.0802978","article-title":"IL-21 mediates suppressive effects via its induction of IL-10.","volume":"182","author":"Spolski","year":"2009","journal-title":"J Immunol"},{"issue":"1","key":"2019111806525622700_B49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-3083.2007.02035.x","article-title":"IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis.","volume":"67","author":"Piao","year":"2008","journal-title":"Scand J Immunol"},{"issue":"5934","key":"2019111806525622700_B50","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1126\/science.1172815","article-title":"IL-21R on T cells is critical for sustained functionality and control of chronic viral infection.","volume":"324","author":"Frohlich","year":"2009","journal-title":"Science"},{"issue":"5934","key":"2019111806525622700_B51","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1126\/science.1175194","article-title":"A vital role for interleukin-21 in the control of a chronic viral infection.","volume":"324","author":"Yi","year":"2009","journal-title":"Science"},{"issue":"5934","key":"2019111806525622700_B52","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.1174182","article-title":"IL-21 is required to control chronic viral infection.","volume":"324","author":"Elsaesser","year":"2009","journal-title":"Science"},{"issue":"3","key":"2019111806525622700_B53","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00007890-198703000-00018","article-title":"Interferon alpha\/beta synthesis during acute graft-versus-host disease.","volume":"43","author":"Reyes","year":"1987","journal-title":"Transplantation"},{"issue":"2","key":"2019111806525622700_B54","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1189\/jlb.1003488","article-title":"IFN-alpha regulates IL-21 and IL-21R expression in human NK and T cells.","volume":"76","author":"Strengell","year":"2004","journal-title":"J Leukoc Biol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/2\/446\/1343837\/zh802811000446.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/2\/446\/1343837\/zh802811000446.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T22:03:21Z","timestamp":1712441001000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/2\/446\/28508\/Abrogation-of-donor-Tcell-IL21-signaling-leads-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,14]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,7,14]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2010-07-294785","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,14]]}}}